Exclusive: GlaxoSmithKline faces fresh drug bribery claims in Syria

By | 11/08/2014

LONDON (Reuters) – GlaxoSmithKline faces new allegations that it bribed Syrian doctors and officials to boost sales of its medicines, following recent accusations of corruption in its non-prescription business in the country.

Link to article: feeds.reuters.com/~r/reuters/businessNews/~3/PfgzULhQve0/story01.htm

Category: Business

About PentaBytes

PentaBytes is a Blog or Digital Magazine with direct link for the best selected news in real time. The last news about Technology, Economy, Business, Startups, Society, Travel, etc. Interviews and interesting articles. You can contact with us in the contact page. Thanks.

Leave a Reply

Your email address will not be published. Required fields are marked *